This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4 mg naloxone hydrochloride nasal spray, a critical medication used to reverse opioid overdoses. The delivery order is valued at $2,188.87 and has a completion date of February 26, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,206.16 firm fixed-price delivery order is for the supply of 4 mg naloxone hydrochloride nasal spray, a critical medication used to rapidly reverse opioid overdoses. The contract has an ultimate completion date of January 30, 2025 and was awarded on January 29, 2025. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,355.00 fixed-price delivery order is for the supply of NALOXONE HCL 4 MG NASAL SPRAY 2S, a critical medication used for the treatment of opioid overdose. The contract has an ultimate completion date of February 21, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,275.16 firm fixed-price delivery order is for the supply of 4 mg naloxone hydrochloride nasal spray, a critical medication used to reverse opioid overdoses. The contract has an ultimate completion date of June 7, 2023 and was awarded on June 6, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,957.10 firm fixed-price contract is for the supply of Naloxone HCL 4 mg nasal spray, a medication used to treat opioid overdose. The contract has a performance period ending on June 17, 2025. AmerisourceBergen Drug Corp is the prime contractor, with no subcontractors mentioned. This contract is not designated as a set-aside....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,120,273 units of Naloxone HCl 4 mg nasal spray, a medication used to treat opioid overdose. The contract has a firm-fixed price of $1,799.28 and a completion date of May 5, 2025. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,288.70, is for the delivery of NALOXONE HCL 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. This is a firm fixed-price delivery order contract with a completion date of December 3, 2024. The contract was not set aside for any specific business type. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,102.89 firm fixed-price delivery order contract is for the supply of 4 mg naloxone hydrochloride nasal spray. The contract has an ultimate completion date of August 5, 2024 and was awarded on August 2, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,364.04 firm fixed-price award is for the supply of 4,567,104,095 units of 4 mg naloxone hydrochloride nasal spray, which is a critical medication used to reverse opioid overdoses. The award is not designated under any set-aside program, indicating open competition. This delivery order is part of a larger Indefinite...
This is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4 mg Naloxone Hydrochloride Nasal Spray, a critical medication used to reverse opioid overdoses. The total ceiling value of the contract is $1,315.00, with an ultimate completion date of April 2, 2025. This contract award is not associated with any set-aside...